AUM $5.2MER 0.47%NAV $34.64Holdings 74Inception Aug 2022
Price Chart
Key Statistics
Previous Close
$34.48Day Range
N/A52-Week Range
$21.14$35.70
Avg Volume
2.0KDividend Yield
1.00%Expense Ratio
0.47%AUM
$5.2MShares Outstanding
139.6KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 69.37% |
| Canada | 4.71% |
| Ireland | 4.64% |
| United Kingdom | 3.95% |
| Netherlands | 3.87% |
| Sweden | 2.40% |
| South Korea | 2.22% |
| Denmark | 1.99% |
| China | 1.50% |
| Switzerland | 1.34% |
| Japan | 1.30% |
| Australia | 1.02% |
| France | 0.61% |
| Israel | 0.59% |
| Italy | 0.38% |
| Other | 0.10% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- GrowthTechnology
- Inception Date
- Aug 24, 2022
- Exchange
- NYSE_ARCA
- Description
- The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Similar ETFs
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund issued by iShares that launched on Aug 24, 2022. It currently manages $5.2M in assets under management. The fund charges an expense ratio of 0.47%. The fund holds 74 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 40.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | XENE | XENON PHARMACEUTICALS INC | 4.71% | 4,419 | $245K |
| 2 | ARWR | ARROWHEAD PHARMACEUTICALS INC | 4.44% | 3,103 | $231K |
| 3 | ALKS | ALKERMES | 4.20% | 6,446 | $219K |
| 4 | AXSM | AXSOME THERAPEUTICS INC | 4.02% | 1,144 | $209K |
| 5 | CNTA | CENTESSA PHARMACEUTICALS AMERICAN | 3.93% | 5,186 | $204K |
| 6 | ARGX | ARGENX SE ADR | 3.89% | 257 | $203K |
| 7 | PTCT | PTC THERAPEUTICS INC | 3.88% | 2,938 | $202K |
| 8 | PRAX | PRAXIS PRECISION MEDICINES INC | 3.77% | 594 | $196K |
| 9 | SRRK | SCHOLAR ROCK HOLDING CORP | 3.72% | 4,075 | $193K |
| 10 | BIIB | BIOGEN INC | 3.63% | 1,004 | $189K |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | 3.63% | 1,448 | $189K |
| 12 | ACAD | ACADIA PHARMACEUTICALS INC | 3.54% | 8,328 | $184K |
| 13 | DNTH | DIANTHUS THERAPEUTICS INC | 3.45% | 1,998 | $179K |
| 14 | CPRX | CATALYST PHARMACEUTICALS INC | 3.22% | 6,048 | $167K |
| 15 | DNLI | DENALI THERAPEUTICS INC | 2.92% | 7,800 | $152K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | -0.90% | |
| 1M | +11.55% | |
| 3M | +3.97% | |
| 6M | +13.55% | |
| YTD | +7.99% | |
| 1Y | +53.12% | |
| 3Y | +36.31% | |
| 5Y | +39.71% |
Moving Averages
20-Day MA
$34.22
Above 20-Day MA50-Day MA
$32.69
Above 50-Day MA200-Day MA
$29.22
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$35.70
Current Price
$34.77
52-Week Low
$21.14
$21.14$35.70
Current Yield
1.00%
Annual Dividend
$0.4355
Frequency
1x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 17, 2024 | $0.1011 | Dec 20, 2024 |
| Dec 20, 2023 | $0.0063 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0082 | Jun 13, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | IBRN | Healthcare(212 ETFs) | Growth(409 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.47% | 0.61% | 0.66% |
| AUM | $5.2M | $1.20B | $2.74B |
| Dividend Yield | 1.00% | 3.25% | 5.84% |
| Avg Volume | 2.0K | 339.2K | 199.6K |
| Holdings | 74 | 181 | 82 |
| Performance | |||
| 1-Month Return | +11.24% | +7.61% | +10.57% |
| 6-Month Return | +17.67% | +4.67% | +0.31% |
| YTD Return | +6.21% | +1.95% | +2.50% |
| 1-Year Return | +56.00% | +27.17% | +25.13% |
Compare with Another ETF
Search for an ETF to compare with IBRN:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.